respiratori
syncyti
viru
rsv
infect
one
common
caus
hospit
children
develop
countri
implic
caus
asthma
aim
character
cytokin
profil
nasopharyng
aspir
npa
taken
infant
upper
respiratori
tract
infect
investig
whether
rsv
induc
uniqu
immun
respons
compar
virus
addit
sought
determin
whether
profil
influenc
infant
atop
statu
prospect
birth
cohort
babi
high
risk
atopi
recruit
ratio
thelper
cytokin
interferon
gamma
ifng
thelper
like
cytokin
npa
determin
episod
respiratori
tract
infect
first
year
viral
aetiolog
respiratori
tract
infect
determin
use
polymeras
chain
reaction
pcr
cultur
immunofluoresc
atop
statu
ascertain
year
age
use
skin
prick
test
particip
recruit
antenat
subsequ
follow
commun
sixti
babi
one
parent
atop
enrol
studi
ifng
ratio
npa
upper
respiratori
tract
infect
correl
viral
aetiolog
atop
statu
main
outcom
measur
mean
ifng
ratio
significantli
lower
due
lower
ifng
rsv
infect
infect
virus
p
cytokin
ratio
howev
differ
infant
without
wheez
urti
p
infant
atop
nonatop
p
studi
suggest
rsv
associ
lower
ifng
product
young
babi
regardless
atop
statu
compar
upper
respiratori
tract
infect
either
anoth
viru
detect
viral
identif
made
evid
frequent
infect
earli
life
protect
develop
atopi
clear
howev
infect
protect
whether
infect
may
fact
promot
develop
atopi
paradigm
central
hypothes
relationship
infect
develop
atopi
cell
primarili
produc
ifng
involv
cell
mediat
immun
inhibit
b
cell
isotyp
switch
ige
product
cell
produc
promot
ige
product
import
eosinophil
growth
factor
least
function
type
cytokin
inhibit
ifng
product
theori
multipl
infect
earli
life
may
enhanc
develop
type
cell
thu
protect
differenti
possibl
atopi
role
respiratori
viral
infect
develop
atopi
asthma
present
enigma
mani
studi
shown
increas
incid
wheez
respiratori
symptom
sever
rsv
infect
childhood
compar
control
hospit
rsv
question
aris
rsv
caus
uncov
asthma
least
childhood
mechan
one
possibl
rsv
promot
immun
respons
babi
aim
first
measur
ifng
level
npa
babi
respiratori
tract
infect
compar
level
atop
nonatop
babi
secondli
sought
ascertain
whether
rsv
infect
promot
differ
cytokin
profil
induc
viral
infect
third
aim
see
differ
nasopharyng
cytokin
profil
respiratori
tract
infect
children
wheez
wheez
acut
ill
babi
due
born
parent
one
atop
recruit
antenat
clinic
kgv
hospit
camperdown
nsw
westmead
hospit
westmead
nsw
obtain
inform
consent
skin
prick
test
spt
common
allergen
perform
parent
one
parent
posit
least
one
allergen
babi
includ
studi
method
npa
collect
report
detail
previous
briefli
npa
collect
suction
nasopharynx
portabl
suction
unit
collect
child
place
supin
posit
steril
feed
tube
attach
mucu
trap
maerisk
indopla
sydney
australia
pass
nasopharynx
gentl
suction
appli
salin
instil
prior
suction
least
ml
aspir
collect
child
specimen
place
ice
transport
immedi
laboratori
specimen
receiv
laboratori
within
h
collect
specimen
dilut
volum
ml
use
phosphat
buffer
salin
pb
specimen
centrifug
g
min
visibl
cellular
debri
remov
measur
ifng
use
enzymelink
immunosorb
assay
elisa
also
measur
could
detect
cytokin
npa
discontinu
measur
assay
perform
use
techniqu
alreadi
standard
laboratori
purifi
pharmingen
san
diego
ca
usa
use
standard
minimum
detect
level
pgml
ifng
level
measur
use
pelikin
human
ifng
elisa
kit
pelikin
netherland
lower
limit
detect
pgml
ifng
data
analysi
cytokin
level
higher
background
read
lower
lower
limit
detect
record
half
lower
limit
detect
ratio
ifng
calcul
order
control
dilut
factor
npa
immunofluoresc
rsv
use
fluoresceinlabel
rsv
antiserum
franc
viral
cultur
monkey
kidney
cell
diploid
fibroblast
cell
perform
depart
virolog
royal
alexandra
hospit
children
westmead
hospit
briefli
nasal
aspir
gentli
suspend
cold
mem
centrifug
supernat
remov
reserv
immedi
inocul
tissu
cultur
tube
cell
pellet
use
viral
immunofluoresc
viral
cultur
incub
c
day
check
cytopath
effect
everi
second
day
revers
transcriptas
rt
pcr
rhinoviru
coronavirus
perform
dr
david
smith
sir
charl
gardin
hospit
perth
australia
method
use
rhinoviru
pcr
describ
full
ireland
et
al
briefli
seminest
rtpcr
direct
conserv
sequenc
untransl
region
use
first
run
detect
picornavirus
second
run
rhinoviru
primer
use
specif
identif
coronaviru
pcr
multiplex
nest
rtpcr
direct
nucleocapsid
gene
coronavirus
describ
full
myint
et
al
patient
followup
birth
year
parent
ask
report
respiratori
symptom
note
child
first
year
life
addit
contact
weekli
ask
standard
seri
question
pertain
presenc
respiratori
symptom
includ
rhinorrhoea
cough
wheez
parent
report
respiratori
symptom
home
visit
perform
home
visit
child
examin
rhinorrhoea
present
npa
collect
per
protocol
order
identifi
new
episod
ill
npa
collect
less
day
sinc
last
collect
increas
yield
viral
identif
specimen
collect
perform
within
day
first
report
symptom
studi
nurs
blind
result
laboratori
test
conduct
previous
child
administ
detail
questionnair
regard
demograph
detail
babi
health
past
year
questionnair
base
intern
studi
asthma
allergi
childhood
isaac
protocol
provid
standard
set
question
assess
presenc
symptom
sign
diseas
paediatrician
also
examin
child
posit
answer
eczema
question
children
spt
perform
venou
blood
collect
purpos
studi
atopi
defin
posit
reaction
one
skin
test
allergen
test
standard
protein
extract
greer
milk
egg
peanut
der
dermatophagoid
pteronyssinu
der
farina
alternaria
fel
cat
allergen
grass
mix
studi
approv
ethic
committe
royal
alexandra
hospit
children
royal
princ
alfr
hospit
kgv
westmead
hospit
ifng
valu
normal
distribut
therefor
present
median
rang
differ
cytokin
concentr
rsv
rsvsampl
assess
use
mannwhitney
rank
sum
test
measur
cytokin
level
alon
correct
dilut
factor
therefor
geometr
mean
cytokin
ratio
compar
use
independ
sampl
test
data
analys
use
spss
softwar
sixti
babi
enrol
studi
sampl
collect
analys
mean
number
infect
per
child
per
year
rang
two
hospit
admiss
h
longer
rsv
identifi
two
hospit
infant
remaind
babi
treat
commun
statist
signific
differ
incid
cough
wheez
babi
without
posit
viral
identif
tabl
rsv
identifi
sampl
rhinoviru
parainfluenza
viru
type
four
sampl
adenoviru
influenza
coronaviru
one
sampl
sampl
coronaviru
also
posit
rhinoviru
viru
identifi
sampl
rhinoviru
sampl
identifi
use
cultur
remaind
use
pcr
viru
identifi
sampl
demograph
data
summar
tabl
signific
differ
age
sex
skin
prick
statu
babi
rsv
rsv
ratio
ifng
use
primari
method
compar
sampl
individu
cytokin
concentr
would
confound
differ
volum
secret
obtain
method
comparison
describ
previous
geometr
mean
ifng
ratio
npa
sampl
individu
rsv
ci
significantli
lower
geometr
mean
npa
children
without
rsv
ci
p
fig
level
ifng
nonrsvinfect
sampl
significantli
higher
rsvinfect
sampl
p
differ
level
two
group
tabl
geometr
mean
ifng
ratio
npa
rhinoviru
identifi
ci
significantli
differ
geometr
mean
ratio
sampl
rhinoviru
identifi
ci
p
geometr
mean
ratio
ifng
rsv
sampl
ci
significantli
lower
ratio
rhinoviru
sampl
ci
p
geometr
mean
ifng
ratio
sampl
viru
identifi
ci
significantli
differ
ratio
sampl
viru
identifi
ci
p
geometr
mean
ifng
ratio
rsv
sampl
ci
lower
specimen
viru
ci
six
sampl
viru
rhinoviru
viru
ci
identifi
differ
reach
signific
level
p
respect
thirtythre
sampl
collect
spt
babi
sptbabi
geometr
mean
ratio
sampl
subject
posit
spt
ci
significantli
differ
neg
spt
ci
p
wheez
heard
occas
npa
collect
subject
wheez
respiratori
tract
infect
median
age
day
significantli
older
subject
wheez
median
age
day
p
tabl
geometr
mean
ifng
ratio
children
wheez
respiratori
tract
infect
ci
children
wheez
ci
p
although
children
wheez
tend
lower
ratio
differ
signific
tabl
found
ratio
ifng
lower
rsv
npa
infant
compar
rsv
npa
level
ifng
lower
sampl
rsv
identifi
nonrsvinfect
sampl
differ
level
two
group
differ
found
rhinoviru
rhinovirussampl
npa
viru
identifi
compar
viral
isol
detect
differ
ifng
ratio
atop
nonatop
babi
babi
without
wheez
respiratori
tract
infect
studi
cohort
babi
high
risk
atopi
order
control
consider
influenc
famili
histori
develop
atopi
fact
babi
posit
famili
histori
atopi
also
lower
ifng
level
birth
earlier
work
shown
level
babi
compar
secret
upper
lower
airway
van
schaik
et
al
use
similar
collect
techniqu
also
demonstr
strong
correl
r
ifng
nonrsv
rsv
ratio
npa
endotrach
aspir
intub
babi
rate
posit
viral
identif
studi
consist
find
anoth
studi
agecompar
infant
report
posit
rate
communitybas
studi
rhinoviru
frequent
identifi
viral
pathogen
concur
previous
report
data
rhinoviru
caus
identifi
communitybas
infect
earli
studi
demonstr
lower
product
interferon
nasal
wash
rsv
infect
compar
viral
infect
like
howev
ifna
interferon
measur
easili
report
subsequ
studi
lower
airway
asthmat
increas
cytokin
compar
control
measur
bronchoalveolar
fluid
studi
show
ifng
ratio
significantli
lower
respiratori
tract
secret
babi
rsv
infect
absolut
ifng
concentr
also
lower
compar
babi
anoth
viru
viru
identifi
caus
respiratori
tract
symptom
suggest
suppress
cytokin
respons
respiratori
tract
level
rsv
infect
would
also
suggest
viral
infect
particular
rhinoviru
upregul
ifng
product
acut
infect
moreov
result
demonstr
differ
cytokin
respons
atop
nonatop
babi
suggest
cytokin
respons
rsv
due
babi
preexist
atop
statu
sheeran
et
al
found
concentr
respiratori
secret
obtain
children
rsv
infect
significantli
greater
sampl
obtain
control
children
also
suggest
type
respons
rsv
infect
increas
cytokin
express
report
peripher
blood
mononuclear
cell
pbmc
healthi
adult
infect
rsv
type
respons
pbmc
babi
hospit
acut
bronchiol
renzi
et
al
found
children
hospit
acut
rsv
infect
develop
asthma
significantli
lower
ifng
level
produc
pbmc
time
acut
rsv
infect
asthma
suggest
children
go
develop
asthma
bronchiol
either
exist
defici
ifng
product
respond
viru
differ
way
children
develop
asthma
anim
studi
shown
mice
sensit
ovalbumin
rsv
infect
profil
stimul
pbmc
ovalbumin
compar
mice
sensit
sham
infect
mice
sensit
ovalbumin
rsv
infect
develop
increas
airway
respons
methacholin
author
conclud
rsv
infect
result
airway
hyperrespons
acut
phase
lead
chang
immun
function
enhanc
effect
airway
sensit
antigen
infect
light
anim
model
describ
one
specul
suscept
individu
rsv
earli
infanc
expos
appropri
allergen
critic
time
immun
system
may
prime
atop
respons
studi
show
acut
rsv
infect
unlik
rhinoviru
respiratori
viral
infect
associ
lower
ifng
level
npa
regardless
atop
statu
unlik
childhood
respiratori
infect
rsv
may
serv
except
hygien
hypothesi
acut
infect
rais
possibl
pathogenesi
wheez
perhap
asthma
follow
rsv
suscept
individu
relat
develop
cytokin
profil
respiratori
tract
asthma
may
becom
appar
manifest
infant
older
therefor
plan
follow
cohort
regard
atopi
asthma
valuabl
relat
outcom
current
cytokin
measur
p
use
independ
sampl
ttest
p
use
independ
sampl
ttest
